Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Velcera was a companion animal health company that specialized in developing and commercializing over-the-counter (OTC) veterinary medicines. The company is best known for its PetArmor brand, which provided affordable flea and tick treatments using the same active ingredients as leading prescription products. Velcera also pioneered the ProMist technology, a patented transmucosal oral mist delivery system designed to enhance the administration of medications for pain and allergies in pets. In 2013, Velcera was acquired by Perrigo for $160 million, significantly expanding Perrigo's footprint in the animal healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Velcera Pharmaceuticals.